ILMN
ILLUMINA, INC.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$226.10
−5.08%Margins
Gross margin
68.3%
EBITDA margin
30.5%
EBIT margin
22.4%
Net margin
19.7%
FCF margin
23.3%
28.5%
Return on equity
13.1%
Return on assets
18.6%
Return on invested capital
0.67x
Asset turnover
$1.2B
Cash from operations
$8.84
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026